Target intelligence / Profile preview

ERRFI1 divergent transcript (ERRFI1-DT)

Target
ERRFI1-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

ERRFI1-DT (ERRFI1 divergent transcript) is annotated as a divergent transcript at the *ERRFI1* gene locus, which means it is a long non-coding RNA gene found within 300–500 nucleotides of the protein-coding *ERRFI1* gene and transcribed in the opposite direction[1][3]. *ERRFI1-DT* itself is not a protein-coding gene, and there is currently no evidence indicating it is a therapeutic target, biomarker, or has a defined molecular or disease-associated function in the literature or gene databases[1][3]. Most biological and clinical roles attributed to the *ERRFI1* locus refer to the protein-coding gene, NOT the divergent transcript. Key Note: If the intention was to refer to *ERRFI1* (ERBB receptor feedback inhibitor 1, an established protein-coding negative regulator of EGFR signaling and studied cancer suppressor), that is a distinct molecule from ERRFI1-DT[5]. ERRFI1-DT is a non-coding RNA with insufficient functional characterization and is not a recognized molecular target.

Other names
ERRFI1-DTERRFI1 divergent transcript
02

Biological functions

Not explicitly characterizedERRFI1, the protein-coding gene at this locus, is involved in negative feedback regulation of EGFR signaling, but ERRFI1-DT's function is not defined.
03

Disease associations

OtherNo specific disease association reported for ERRFI1-DT; ERRFI1 implicated in cancer and endometrial disease, but not the divergent transcript.

Beyond the preview

Go deeper on ERRFI1 divergent transcript (ERRFI1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ERRFI1 divergent transcript (ERRFI1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call